Table of Content

1 Klebsiella Pneumoniae Infection Drug Market Overview
1.1 Klebsiella Pneumoniae Infection Drug Product Scope
1.2 Klebsiella Pneumoniae Infection Drug Segment by Type
1.2.1 Global Klebsiella Pneumoniae Infection Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 ATI-1503
1.2.3 CA-824
1.2.4 CC-1807
1.2.5 Cefiderocol
1.2.6 Debio-1454
1.2.7 EBX-004
1.2.8 Others
1.3 Klebsiella Pneumoniae Infection Drug Segment by Application
1.3.1 Global Klebsiella Pneumoniae Infection Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Klebsiella Pneumoniae Infection Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Klebsiella Pneumoniae Infection Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Klebsiella Pneumoniae Infection Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Klebsiella Pneumoniae Infection Drug Price Trends (2016-2027)

2 Klebsiella Pneumoniae Infection Drug Estimates and Forecasts by Region
2.1 Global Klebsiella Pneumoniae Infection Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Klebsiella Pneumoniae Infection Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Region (2016-2021)
2.3 Global Klebsiella Pneumoniae Infection Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Klebsiella Pneumoniae Infection Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Klebsiella Pneumoniae Infection Drug Estimates and Projections (2016-2027)
2.4.2 Europe Klebsiella Pneumoniae Infection Drug Estimates and Projections (2016-2027)
2.4.3 China Klebsiella Pneumoniae Infection Drug Estimates and Projections (2016-2027)
2.4.4 Japan Klebsiella Pneumoniae Infection Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Klebsiella Pneumoniae Infection Drug Estimates and Projections (2016-2027)
2.4.6 India Klebsiella Pneumoniae Infection Drug Estimates and Projections (2016-2027)

3 Global Klebsiella Pneumoniae Infection Drug Competition Landscape by Players
3.1 Global Top Klebsiella Pneumoniae Infection Drug Players by Sales (2016-2021)
3.2 Global Top Klebsiella Pneumoniae Infection Drug Players by Revenue (2016-2021)
3.3 Global Klebsiella Pneumoniae Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Klebsiella Pneumoniae Infection Drug as of 2020)
3.4 Global Klebsiella Pneumoniae Infection Drug Average Price by Company (2016-2021)
3.5 Manufacturers Klebsiella Pneumoniae Infection Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Klebsiella Pneumoniae Infection Drug Market Size by Type
4.1 Global Klebsiella Pneumoniae Infection Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Klebsiella Pneumoniae Infection Drug Price by Type (2016-2021)
4.2 Global Klebsiella Pneumoniae Infection Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Klebsiella Pneumoniae Infection Drug Price Forecast by Type (2022-2027)

5 Global Klebsiella Pneumoniae Infection Drug Market Size by Application
5.1 Global Klebsiella Pneumoniae Infection Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Klebsiella Pneumoniae Infection Drug Price by Application (2016-2021)
5.2 Global Klebsiella Pneumoniae Infection Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Klebsiella Pneumoniae Infection Drug Price Forecast by Application (2022-2027)

6 North America Klebsiella Pneumoniae Infection Drug Market Facts & Figures
6.1 North America Klebsiella Pneumoniae Infection Drug Sales by Company
6.1.1 North America Klebsiella Pneumoniae Infection Drug Sales by Company (2016-2021)
6.1.2 North America Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021)
6.2 North America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type
6.2.1 North America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2022-2027)
6.3 North America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application
6.3.1 North America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application (2022-2027)

7 Europe Klebsiella Pneumoniae Infection Drug Market Facts & Figures
7.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Company
7.1.1 Europe Klebsiella Pneumoniae Infection Drug Sales by Company (2016-2021)
7.1.2 Europe Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021)
7.2 Europe Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type
7.2.1 Europe Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)

8 China Klebsiella Pneumoniae Infection Drug Market Facts & Figures
8.1 China Klebsiella Pneumoniae Infection Drug Sales by Company
8.1.1 China Klebsiella Pneumoniae Infection Drug Sales by Company (2016-2021)
8.1.2 China Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021)
8.2 China Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type
8.2.1 China Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2022-2027)
8.3 China Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application
8.3.1 China 163 Sales Breakdown by Application (2016-2021)
8.3.2 China 163 Sales Breakdown by Application (2022-2027)

9 Japan Klebsiella Pneumoniae Infection Drug Market Facts & Figures
9.1 Japan Klebsiella Pneumoniae Infection Drug Sales by Company
9.1.1 Japan Klebsiella Pneumoniae Infection Drug Sales by Company (2016-2021)
9.1.2 Japan Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021)
9.2 Japan Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type
9.2.1 Japan Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Klebsiella Pneumoniae Infection Drug Market Facts & Figures
10.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales by Company
10.1.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type
10.2.1 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Klebsiella Pneumoniae Infection Drug Market Facts & Figures
11.1 India Klebsiella Pneumoniae Infection Drug Sales by Company
11.1.1 India Klebsiella Pneumoniae Infection Drug Sales by Company (2016-2021)
11.1.2 India Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021)
11.2 India Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type
11.2.1 India Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Klebsiella Pneumoniae Infection Drug Sales Breakdown by Type (2022-2027)
11.3 India Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application
11.3.1 India Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Klebsiella Pneumoniae Infection Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Klebsiella Pneumoniae Infection Drug Business
12.1 Acies Bio doo
12.1.1 Acies Bio doo Corporation Information
12.1.2 Acies Bio doo Business Overview
12.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Acies Bio doo Klebsiella Pneumoniae Infection Drug Products Offered
12.1.5 Acies Bio doo Recent Development
12.2 Appili Therapeutics
12.2.1 Appili Therapeutics Corporation Information
12.2.2 Appili Therapeutics Business Overview
12.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Products Offered
12.2.5 Appili Therapeutics Recent Development
12.3 Debiopharm International SA
12.3.1 Debiopharm International SA Corporation Information
12.3.2 Debiopharm International SA Business Overview
12.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Products Offered
12.3.5 Debiopharm International SA Recent Development
12.4 Evaxion Biotech ApS
12.4.1 Evaxion Biotech ApS Corporation Information
12.4.2 Evaxion Biotech ApS Business Overview
12.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Products Offered
12.4.5 Evaxion Biotech ApS Recent Development
12.5 F. Hoffmann-La Roche Ltd
12.5.1 F. Hoffmann-La Roche Ltd Corporation Information
12.5.2 F. Hoffmann-La Roche Ltd Business Overview
12.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Products Offered
12.5.5 F. Hoffmann-La Roche Ltd Recent Development
12.6 FOB Synthesis Inc
12.6.1 FOB Synthesis Inc Corporation Information
12.6.2 FOB Synthesis Inc Business Overview
12.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Products Offered
12.6.5 FOB Synthesis Inc Recent Development
12.7 ImmunoClin Corp
12.7.1 ImmunoClin Corp Corporation Information
12.7.2 ImmunoClin Corp Business Overview
12.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Products Offered
12.7.5 ImmunoClin Corp Recent Development
12.8 Innovation Pharmaceuticals Inc
12.8.1 Innovation Pharmaceuticals Inc Corporation Information
12.8.2 Innovation Pharmaceuticals Inc Business Overview
12.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Products Offered
12.8.5 Innovation Pharmaceuticals Inc Recent Development
12.9 Kyorin Pharmaceutical Co Ltd
12.9.1 Kyorin Pharmaceutical Co Ltd Corporation Information
12.9.2 Kyorin Pharmaceutical Co Ltd Business Overview
12.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Products Offered
12.9.5 Kyorin Pharmaceutical Co Ltd Recent Development
12.10 Melinta Therapeutics Inc
12.10.1 Melinta Therapeutics Inc Corporation Information
12.10.2 Melinta Therapeutics Inc Business Overview
12.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Products Offered
12.10.5 Melinta Therapeutics Inc Recent Development
12.11 Nosopharm SAS
12.11.1 Nosopharm SAS Corporation Information
12.11.2 Nosopharm SAS Business Overview
12.11.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Products Offered
12.11.5 Nosopharm SAS Recent Development
12.12 Peptilogics Inc
12.12.1 Peptilogics Inc Corporation Information
12.12.2 Peptilogics Inc Business Overview
12.12.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Products Offered
12.12.5 Peptilogics Inc Recent Development
12.13 Pfizer Inc
12.13.1 Pfizer Inc Corporation Information
12.13.2 Pfizer Inc Business Overview
12.13.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Pfizer Inc Klebsiella Pneumoniae Infection Drug Products Offered
12.13.5 Pfizer Inc Recent Development
12.14 Phico Therapeutics Ltd
12.14.1 Phico Therapeutics Ltd Corporation Information
12.14.2 Phico Therapeutics Ltd Business Overview
12.14.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Products Offered
12.14.5 Phico Therapeutics Ltd Recent Development
12.15 Sarepta Therapeutics Inc
12.15.1 Sarepta Therapeutics Inc Corporation Information
12.15.2 Sarepta Therapeutics Inc Business Overview
12.15.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Products Offered
12.15.5 Sarepta Therapeutics Inc Recent Development
12.16 Shionogi & Co Ltd
12.16.1 Shionogi & Co Ltd Corporation Information
12.16.2 Shionogi & Co Ltd Business Overview
12.16.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Products Offered
12.16.5 Shionogi & Co Ltd Recent Development
12.17 Syntiron LLC
12.17.1 Syntiron LLC Corporation Information
12.17.2 Syntiron LLC Business Overview
12.17.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Syntiron LLC Klebsiella Pneumoniae Infection Drug Products Offered
12.17.5 Syntiron LLC Recent Development
12.18 Tetraphase Pharmaceuticals Inc
12.18.1 Tetraphase Pharmaceuticals Inc Corporation Information
12.18.2 Tetraphase Pharmaceuticals Inc Business Overview
12.18.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Products Offered
12.18.5 Tetraphase Pharmaceuticals Inc Recent Development

13 Klebsiella Pneumoniae Infection Drug Manufacturing Cost Analysis
13.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
13.4 Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Klebsiella Pneumoniae Infection Drug Distributors List
14.3 Klebsiella Pneumoniae Infection Drug Customers

15 Market Dynamics
15.1 Klebsiella Pneumoniae Infection Drug Market Trends
15.2 Klebsiella Pneumoniae Infection Drug Drivers
15.3 Klebsiella Pneumoniae Infection Drug Market Challenges
15.4 Klebsiella Pneumoniae Infection Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Klebsiella Pneumoniae Infection Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Klebsiella Pneumoniae Infection Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Klebsiella Pneumoniae Infection Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Region (2016-2021)
Table 6. Global Klebsiella Pneumoniae Infection Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Region (2016-2021)
Table 8. Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Klebsiella Pneumoniae Infection Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Klebsiella Pneumoniae Infection Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Klebsiella Pneumoniae Infection Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Klebsiella Pneumoniae Infection Drug Sales Share by Company (2016-2021)
Table 14. Global Klebsiella Pneumoniae Infection Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Company (2016-2021)
Table 16. Global Klebsiella Pneumoniae Infection Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Klebsiella Pneumoniae Infection Drug as of 2020)
Table 17. Global Klebsiella Pneumoniae Infection Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Klebsiella Pneumoniae Infection Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Klebsiella Pneumoniae Infection Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Klebsiella Pneumoniae Infection Drug Sales Share by Type (2016-2021)
Table 23. Global Klebsiella Pneumoniae Infection Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Klebsiella Pneumoniae Infection Drug Sales Share by Type (2022-2027)
Table 26. Global Klebsiella Pneumoniae Infection Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Type (2022-2027)
Table 28. Global Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Klebsiella Pneumoniae Infection Drug Sales Share by Application (2016-2021)
Table 31. Global Klebsiella Pneumoniae Infection Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Klebsiella Pneumoniae Infection Drug Sales Share by Application (2022-2027)
Table 35. Global Klebsiella Pneumoniae Infection Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Application (2022-2027)
Table 37. Global Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2016-2021)
Table 40. North America Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2021)
Table 44. North America Klebsiella Pneumoniae Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2022-2027)
Table 46. North America Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2021)
Table 48. North America Klebsiella Pneumoniae Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Klebsiella Pneumoniae Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Klebsiella Pneumoniae Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2022-2027)
Table 62. China Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2016-2021)
Table 64. China Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2016-2021)
Table 66. China Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2021)
Table 68. China Klebsiella Pneumoniae Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2022-2027)
Table 70. China Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2021)
Table 72. China Klebsiella Pneumoniae Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Klebsiella Pneumoniae Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Klebsiella Pneumoniae Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2022-2027)
Table 98. India Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Klebsiella Pneumoniae Infection Drug Sales Market Share by Company (2016-2021)
Table 100. India Klebsiella Pneumoniae Infection Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Klebsiella Pneumoniae Infection Drug Revenue Market Share by Company (2016-2021)
Table 102. India Klebsiella Pneumoniae Infection Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2016-2021)
Table 104. India Klebsiella Pneumoniae Infection Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Klebsiella Pneumoniae Infection Drug Sales Market Share by Type (2022-2027)
Table 106. India Klebsiella Pneumoniae Infection Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2016-2021)
Table 108. India Klebsiella Pneumoniae Infection Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Klebsiella Pneumoniae Infection Drug Sales Market Share by Application (2022-2027)
Table 110. Acies Bio doo Corporation Information
Table 111. Acies Bio doo Description and Business Overview
Table 112. Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Acies Bio doo Klebsiella Pneumoniae Infection Drug Product
Table 114. Acies Bio doo Recent Development
Table 115. Appili Therapeutics Corporation Information
Table 116. Appili Therapeutics Description and Business Overview
Table 117. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Product
Table 119. Appili Therapeutics Recent Development
Table 120. Debiopharm International SA Corporation Information
Table 121. Debiopharm International SA Description and Business Overview
Table 122. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Product
Table 124. Debiopharm International SA Recent Development
Table 125. Evaxion Biotech ApS Corporation Information
Table 126. Evaxion Biotech ApS Description and Business Overview
Table 127. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Product
Table 129. Evaxion Biotech ApS Recent Development
Table 130. F. Hoffmann-La Roche Ltd Corporation Information
Table 131. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 132. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Product
Table 134. F. Hoffmann-La Roche Ltd Recent Development
Table 135. FOB Synthesis Inc Corporation Information
Table 136. FOB Synthesis Inc Description and Business Overview
Table 137. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Product
Table 139. FOB Synthesis Inc Recent Development
Table 140. ImmunoClin Corp Corporation Information
Table 141. ImmunoClin Corp Description and Business Overview
Table 142. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Product
Table 144. ImmunoClin Corp Recent Development
Table 145. Innovation Pharmaceuticals Inc Corporation Information
Table 146. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Innovation Pharmaceuticals Inc Description and Business Overview
Table 148. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product
Table 149. Innovation Pharmaceuticals Inc Recent Development
Table 150. Kyorin Pharmaceutical Co Ltd Corporation Information
Table 151. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Kyorin Pharmaceutical Co Ltd Description and Business Overview
Table 153. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Product
Table 154. Kyorin Pharmaceutical Co Ltd Recent Development
Table 155. Melinta Therapeutics Inc Corporation Information
Table 156. Melinta Therapeutics Inc Description and Business Overview
Table 157. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product
Table 159. Melinta Therapeutics Inc Recent Development
Table 160. Nosopharm SAS Corporation Information
Table 161. Nosopharm SAS Description and Business Overview
Table 162. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Product
Table 164. Nosopharm SAS Recent Development
Table 165. Peptilogics Inc Corporation Information
Table 166. Peptilogics Inc Description and Business Overview
Table 167. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Product
Table 169. Peptilogics Inc Recent Development
Table 170. Pfizer Inc Corporation Information
Table 171. Pfizer Inc Description and Business Overview
Table 172. Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Pfizer Inc Klebsiella Pneumoniae Infection Drug Product
Table 174. Pfizer Inc Recent Development
Table 175. Phico Therapeutics Ltd Corporation Information
Table 176. Phico Therapeutics Ltd Description and Business Overview
Table 177. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Product
Table 179. Phico Therapeutics Ltd Recent Development
Table 180. Sarepta Therapeutics Inc Corporation Information
Table 181. Sarepta Therapeutics Inc Description and Business Overview
Table 182. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Product
Table 184. Sarepta Therapeutics Inc Recent Development
Table 185. Shionogi & Co Ltd Corporation Information
Table 186. Shionogi & Co Ltd Description and Business Overview
Table 187. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Product
Table 189. Shionogi & Co Ltd Recent Development
Table 190. Syntiron LLC Corporation Information
Table 191. Syntiron LLC Description and Business Overview
Table 192. Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. Syntiron LLC Klebsiella Pneumoniae Infection Drug Product
Table 194. Syntiron LLC Recent Development
Table 195. Tetraphase Pharmaceuticals Inc Corporation Information
Table 196. Tetraphase Pharmaceuticals Inc Description and Business Overview
Table 197. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Product
Table 199. Tetraphase Pharmaceuticals Inc Recent Development
Table 200. Production Base and Market Concentration Rate of Raw Material
Table 201. Key Suppliers of Raw Materials
Table 202. Klebsiella Pneumoniae Infection Drug Distributors List
Table 203. Klebsiella Pneumoniae Infection Drug Customers List
Table 204. Klebsiella Pneumoniae Infection Drug Market Trends
Table 205. Klebsiella Pneumoniae Infection Drug Market Drivers
Table 206. Klebsiella Pneumoniae Infection Drug Market Challenges
Table 207. Klebsiella Pneumoniae Infection Drug Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Klebsiella Pneumoniae Infection Drug Product Picture
Figure 2. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2021 & 2027
Figure 3. ATI-1503 Product Picture
Figure 4. CA-824 Product Picture
Figure 5. CC-1807 Product Picture
Figure 6. Cefiderocol Product Picture
Figure 7. Debio-1454 Product Picture
Figure 8. EBX-004 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Klebsiella Pneumoniae Infection Drug Sales Market Share by Application in 2021 & 2027
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global Klebsiella Pneumoniae Infection Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 17. Global Klebsiella Pneumoniae Infection Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 18. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Klebsiella Pneumoniae Infection Drug Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 22. Europe Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Klebsiella Pneumoniae Infection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Klebsiella Pneumoniae Infection Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Klebsiella Pneumoniae Infection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Klebsiella Pneumoniae Infection Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Klebsiella Pneumoniae Infection Drug Players Market Share by Revenue in Klebsiella Pneumoniae Infection Drug: 2016 & 2020
Figure 33. Klebsiella Pneumoniae Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Type (2016-2021)
Figure 35. Global Klebsiella Pneumoniae Infection Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Application (2016-2021)
Figure 37. Global Klebsiella Pneumoniae Infection Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2020
Figure 39. North America Klebsiella Pneumoniae Infection Drug Sales Market Share by Application in 2020
Figure 40. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2020
Figure 41. Europe Klebsiella Pneumoniae Infection Drug Sales Market Share by Application in 2020
Figure 42. China Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2020
Figure 43. China Klebsiella Pneumoniae Infection Drug Sales Market Share by Application in 2020
Figure 44. Japan Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2020
Figure 45. Japan Klebsiella Pneumoniae Infection Drug Sales Market Share by Application in 2020
Figure 46. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2020
Figure 47. Southeast Asia Klebsiella Pneumoniae Infection Drug Sales Market Share by Application in 2020
Figure 48. India Klebsiella Pneumoniae Infection Drug Sales Market Share by Type in 2020
Figure 49. India Klebsiella Pneumoniae Infection Drug Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Klebsiella Pneumoniae Infection Drug
Figure 52. Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug
Figure 53. Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed